UNSPSC 51373303: Acetaminophen/aspirin/caffeine/hydrocodone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373303 Acetaminophen/aspirin/caffeine/hydrocodone is a Commodity code. State and local procurement under this code shows limited direct activity for the specific acetaminophen-combination products named in the taxonomy; instead, recent opportunities reflect broader pharmaceutical procurement encompassing generic multi-source drugs, over-the-counter products, and emergency medical supplies including naloxone. Issuing bodies include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances. The actual buying reflects pharmaceutical supply chain consolidation — vendors compete on pricing, wholesaler relationships, manufacturing compliance, and delivery logistics rather than on individual active pharmaceutical ingredients.

Geographic activity centers on Florida, Texas, and Minnesota, with multistate scope through cooperative purchasing vehicles. Representative recent opportunities include Seminole County, Florida's IFB60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries with electronic bidding and fixed-fee pricing; the Texas Health and Human Services Commission's RFI HHS0017013 (April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson) across multiple state and local facilities in Minnesota and Oregon. Vendors bidding under this code typically must maintain cGMP and Drug Supply Chain Security Act certification, establish relationships with designated pharmaceutical wholesalers, submit pricing in standardized formats with transparent NDC and SKU documentation, and carry substantial commercial general liability and professional liability coverage. Price competitiveness typically weighs heavily in evaluation.